Company intelligence / Profile preview

Xinkai Medicine and Chemical Intermediates

Taizhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Zhejiang Xinkai Pharmaceutical is a specialized manufacturer of pharmaceutical intermediates and fine chemicals based in Taizhou, China. Established in 2004, the company focuses on the large-scale production of chemical building blocks used in the synthesis of active pharmaceutical ingredients (APIs). Their core expertise lies in small molecule chemistry, particularly for cardiovascular, anti-diabetic, and anti-viral medications. Xinkai serves as a key supplier and contract manufacturer for global pharmaceutical companies, operating facilities that emphasize quality control and process optimization.

Therapeutic areas: EndocrinologyCardiovascularInfectious Diseases
Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Xinkai Medicine and Chemical Intermediates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinkai Medicine and Chemical Intermediates.

Explore the full profile